Two Truths Co-Founder Cassie Shortsleeve's Recent Articles

Key Takeaways

• Cassie covers postpartum mental health across multiple platforms
• FDA approval marks first postpartum‑depression medication
• Articles address measles outbreak and pregnancy medication safety
• Freelance pieces explore chronic pain and dream science
• Contributions appear in Women’s Health, MedScape, Goop, Washington Post

Pulse Analysis

Cassie Shortsleeve has positioned herself as a go‑to reporter for women's and reproductive health, leveraging the niche Substack newsletter Two Truths alongside contributions to legacy publications. In an era where misinformation can spread faster than science, her blend of investigative depth and accessible prose offers a reliable bridge between clinicians and the public. The newsletter’s recent series—ranging from a forensic look at postpartum psychosis to the first FDA‑approved pill for postpartum depression—demonstrates her commitment to covering topics that sit at the intersection of medical innovation and personal experience.

The August 2023 story announcing the FDA’s first postpartum‑depression medication highlighted a long‑standing therapeutic gap, offering clinicians a pharmacologic option that could reduce reliance on off‑label antidepressants. Shortsleeve’s March 2025 measles‑outbreak analysis assembled expert opinions that underscored vaccination fatigue and the economic toll of school closures, prompting policymakers to revisit funding for public‑health campaigns. Her January 2026 deep dive into Tylenol’s “black‑box” warnings for pregnant users combined regulatory history with emerging endocrine‑replacement data, giving expectant mothers actionable risk assessments. By weaving scientific nuance with human narratives, each piece drives both awareness and informed decision‑making.

In spring 2026 Shortsleeve broadened her reach with freelance articles for MedScape and Goop, tackling topics from early detection of postpartum psychosis to the neuroscience of dream interpretation and chronic‑pain management for physicians. Publishing across both specialist and lifestyle platforms amplifies her influence, allowing evidence‑based insights to permeate diverse readerships—from busy clinicians to wellness‑focused consumers. This multi‑channel strategy not only elevates her personal brand but also reinforces a larger industry trend: health journalists serving as catalysts for translating complex research into practical guidance. As regulatory landscapes evolve, her continued coverage will likely shape both public perception and policy dialogue.